Walleye Trading’s Medicines Co MDCO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-584,500
| Closed | -$49.6M | – | 4927 |
|
|
2019
Q4 | $49.6M | Buy |
584,500
+564,800
| +2,867% | +$37.7M | 0.34% | 33 |
|
|
2019
Q3 | $985K | Buy |
19,700
+100
| +0.5% | +$3.99K | 0.01% | 1616 |
|
|
2019
Q2 | $715K | Buy |
19,600
+8,800
| +81% | +$287K | 0.01% | 1890 |
|
|
2019
Q1 | $302K | Buy |
10,800
+100
| +0.9% | +$2.36K | ﹤0.01% | 2699 |
|
|
2018
Q4 | $205K | Sell |
10,700
-13,200
| -55% | -$307K | ﹤0.01% | 3379 |
|
|
2018
Q3 | $715K | Sell |
23,900
-2,200
| -8% | -$82.9K | ﹤0.01% | 2475 |
|
|
2018
Q2 | $958K | Buy |
26,100
+14,000
| +116% | +$455K | 0.01% | 2155 |
|
|
2018
Q1 | $399K | Buy |
12,100
+4,900
| +68% | +$153K | ﹤0.01% | 2890 |
|
|
2017
Q4 | $197 | Buy |
7,200
+3,100
| +76% | +$95.5K | ﹤0.01% | 3458 |
|
|
2017
Q3 | $154 | Sell |
4,100
-1,000
| -20% | -$36.9K | ﹤0.01% | 3411 |
|
|
2017
Q2 | $195 | Sell |
5,100
-1,600
| -24% | -$71.3K | ﹤0.01% | 3133 |
|
|
2017
Q1 | $329 | Hold |
6,700
| – | – | ﹤0.01% | 2585 |
|
|
2016
Q4 | $226K | Buy |
6,700
+1,100
| +20% | +$39K | ﹤0.01% | 2707 |
|
|
2016
Q3 | $212K | Buy |
5,600
+400
| +8% | +$15.1K | ﹤0.01% | 2767 |
|
|
2016
Q2 | $175K | Buy |
5,200
+1,700
| +49% | +$59.9K | ﹤0.01% | 3059 |
|
|
2016
Q1 | $111K | Buy |
3,500
+3,400
| +3,400% | +$111K | ﹤0.01% | 3256 |
|
|
2015
Q4 | $4K | Sell |
100
-400
| -80% | -$15.1K | ﹤0.01% | 4998 |
|
|
2015
Q3 | $19K | Buy |
+500
| New | +$17.6K | ﹤0.01% | 4109 |
|
Other funds holding MDCO
Walleye Trading's MDCO Position: Q1 2020 in Review
Walleye Trading sold out of Medicines Co (MDCO) in Q1 2020, closing a stake of 350,318 shares — an estimated $29.8M sold.
Walleye Trading first reported a position in MDCO in Q1 2015 and held it in 8 quarters. The position peaked at $29.8M in Q4 2019. 1 fund tracked by Wall St. Rank holds MDCO as of Q1 2020.
- Walleye Trading reported no remaining Medicines Co position as of Q1 2020 after selling out during the quarter.
- Walleye Trading sold 350,318 Medicines Co shares in Q1 2020, an estimated $29.8M.
- Walleye Trading first reported a position in Medicines Co in Q1 2015 and held it in 8 quarters.
- Walleye Trading's Medicines Co position peaked at $29.8M in Q4 2019.
- 1 fund tracked by Wall St. Rank held Medicines Co as of Q1 2020.
Based on Walleye Trading's 13F filing for Q1 2020, filed 15 May 2020.